Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunogenicity and reactogenicity of fractional, heterologous primary COVID-19 vaccination schedules with BNT162b2 boosters in 5-11-year-old Thai children: A multicenter, prospective, double-blind, randomized control trial.
Wittawatmongkol O, Bunjoungmanee P, Kosalaraksa P, Laoprasopwattana K, Boonsathorn S, Chantasrisawad N, Sudjaritruk T, Niyomnaitham S, Senawong S, Srisutthisamphan K, Quan Toh Z, Rungmaitree S, Nanthapisal S, Phanthanawiboon S, Khantee P, Techasaensiri C, Hirankarn N, Pangprasertkul S, Chokephaibulkit K. Wittawatmongkol O, et al. Among authors: hirankarn n. Vaccine. 2023 Sep 15;41(40):5834-5840. doi: 10.1016/j.vaccine.2023.08.021. Epub 2023 Aug 14. Vaccine. 2023. PMID: 37586956 Free article. Clinical Trial.
Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants.
Niyomnaitham S, Jongkaewwattana A, Meesing A, Pinpathomrat N, Nanthapisal S, Hirankarn N, Siwamogsatham S, Kirdlarp S, Chaiwarith R, Lawpoolsri S, Phanthanawiboon S, Thitithanyanont A, Hansasuta P, Chaiyaroj S, Pitisuttithum P. Niyomnaitham S, et al. Among authors: hirankarn n. Int J Infect Dis. 2023 Apr;129:19-31. doi: 10.1016/j.ijid.2023.01.022. Epub 2023 Jan 20. Int J Infect Dis. 2023. PMID: 36682680 Free PMC article. Clinical Trial.
Dietary pattern and the corresponding gut microbiome in response to immunotherapy in Thai patients with advanced non-small cell lung cancer (NSCLC).
Sitthideatphaiboon P, Somlaw N, Zungsontiporn N, Ouwongprayoon P, Sukswai N, Korphaisarn K, Poungvarin N, Aporntewan C, Hirankarn N, Vinayanuwattikun C, Chanida V. Sitthideatphaiboon P, et al. Among authors: hirankarn n. Sci Rep. 2024 Nov 13;14(1):27791. doi: 10.1038/s41598-024-79339-6. Sci Rep. 2024. PMID: 39537963 Free PMC article.
Self-enhancement lateral flow immunoassay for COVID-19 diagnosis.
Ruantip S, Pimpitak U, Rengpipat S, Pasomsub E, Seepiban C, Gajanandana O, Torvorapanit P, Hirankarn N, Jaru-Ampornpan P, Siwamogsatham S, Pongpaibool P, Siwamogsatham S, Thongchul N, Chaiyo S. Ruantip S, et al. Among authors: hirankarn n. Sens Actuators B Chem. 2023 Aug 15;389:133898. doi: 10.1016/j.snb.2023.133898. Epub 2023 Apr 29. Sens Actuators B Chem. 2023. PMID: 37151731 Free PMC article.
Efficacy and Safety of Cannabis Transdermal Patch for Alleviating Psoriasis Symptoms: Protocol for a Randomized Controlled Trial (CanPatch).
Sermsaksasithorn P, Asawanonda P, Phutrakool P, Ondee T, Chariyavilaskul P, Payungporn S, Pongpirul K, Hirankarn N. Sermsaksasithorn P, et al. Among authors: hirankarn n. Med Cannabis Cannabinoids. 2024 May 30;7(1):99-110. doi: 10.1159/000539492. eCollection 2024 Jan-Dec. Med Cannabis Cannabinoids. 2024. PMID: 39015605 Free PMC article.
188 results